AbCellera Biologics (NASDAQ:ABCL) Sets New 52-Week High After Analyst Upgrade...
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report)’s stock price traded up 8.9% during mid-day...
AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 8.9% on Analyst Upgrade...
Leerink Partnrs upgraded shares of AbCellera Biologics (NASDAQ:ABCL – Free Report) to a strong-buy r...
Leerink Partners began coverage on shares of AbCellera Biologics (NASDAQ:ABCL – Free Report) in a re...